Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary
Rationale & Objective: Studies of immunoglobulin A nephropathy (IgAN) have suggested the therapeutic benefit of simultaneously adding tonsillectomy to corticosteroid therapy. However, the efficacy of tonsillectomy monotherapy in the absence of simultaneous use of corticosteroids is unclear....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Kidney Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590059520301643 |
_version_ | 1818955321804062720 |
---|---|
author | Hirokazu Marumoto Nobuo Tsuboi Tetsuya Kawamura Takashi Yokoo |
author_facet | Hirokazu Marumoto Nobuo Tsuboi Tetsuya Kawamura Takashi Yokoo |
author_sort | Hirokazu Marumoto |
collection | DOAJ |
description | Rationale & Objective: Studies of immunoglobulin A nephropathy (IgAN) have suggested the therapeutic benefit of simultaneously adding tonsillectomy to corticosteroid therapy. However, the efficacy of tonsillectomy monotherapy in the absence of simultaneous use of corticosteroids is unclear. Study Design: Patients with IgAN treated with tonsillectomy monotherapy were analyzed retrospectively. Clinical parameters, including kidney function slope, were compared before and after tonsillectomy. Setting & Participants: Patients with biopsy-proven IgAN who received tonsillectomy monotherapy at our hospital between 2007 and 2018. Results: 20 Japanese patients with IgAN were included in this study (mean follow-up period, 135 months from initial biopsy diagnosis to tonsillectomy). All patients had been treated with renin-angiotensin-aldosterone system inhibitors. 17 patients had a history of induction therapy with corticosteroids. Mean time to tonsillectomy from termination of corticosteroid therapy was 84 months. Hematuria, proteinuria, and clinical remission were achieved in 13 of 17 (76%), 10 of 17 (59%), and 8 of 20 (40%) patients at medians of 3.0, 6.0, and 13.5 months, respectively, after tonsillectomy. The slope of the estimated glomerular filtration rate (eGFR) increased significantly during the 81-month observation period, including the periods before and after tonsillectomy (−2.59 vs 1.05 mL/min/1.73 m2 per year; P < 0.001). The effect on eGFR slope was consistent in 11 patients with reduced GFR (eGFR < 60 mL/min/1.73 m2) at the time of tonsillectomy (−3.07 vs −0.39 mL/min/1.73 m2 per year; P < 0.001). Limitations: Small sample size. Lack of a control (no-tonsillectomy) group due to the difficulty of setting the baseline time point (which corresponded to tonsillectomy in our sample). Potential exclusion of patients with the most severe disease who are likely to receive corticosteroids. Lack of generalizability to patients in other countries. Conclusions: Tonsillectomy monotherapy may prevent kidney function decline in some patients with IgAN with kidney disease that has been progressive despite long-term application of conventional therapies. |
first_indexed | 2024-12-20T10:36:13Z |
format | Article |
id | doaj.art-f9113a2fcd024675b35624839b9ba0f4 |
institution | Directory Open Access Journal |
issn | 2590-0595 |
language | English |
last_indexed | 2024-12-20T10:36:13Z |
publishDate | 2020-09-01 |
publisher | Elsevier |
record_format | Article |
series | Kidney Medicine |
spelling | doaj.art-f9113a2fcd024675b35624839b9ba0f42022-12-21T19:43:37ZengElsevierKidney Medicine2590-05952020-09-0125620628Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language SummaryHirokazu MarumotoNobuo Tsuboi0Tetsuya KawamuraTakashi YokooAddress for Correspondence: Nobuo Tsuboi, MD, PhD, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, Japan.Rationale & Objective: Studies of immunoglobulin A nephropathy (IgAN) have suggested the therapeutic benefit of simultaneously adding tonsillectomy to corticosteroid therapy. However, the efficacy of tonsillectomy monotherapy in the absence of simultaneous use of corticosteroids is unclear. Study Design: Patients with IgAN treated with tonsillectomy monotherapy were analyzed retrospectively. Clinical parameters, including kidney function slope, were compared before and after tonsillectomy. Setting & Participants: Patients with biopsy-proven IgAN who received tonsillectomy monotherapy at our hospital between 2007 and 2018. Results: 20 Japanese patients with IgAN were included in this study (mean follow-up period, 135 months from initial biopsy diagnosis to tonsillectomy). All patients had been treated with renin-angiotensin-aldosterone system inhibitors. 17 patients had a history of induction therapy with corticosteroids. Mean time to tonsillectomy from termination of corticosteroid therapy was 84 months. Hematuria, proteinuria, and clinical remission were achieved in 13 of 17 (76%), 10 of 17 (59%), and 8 of 20 (40%) patients at medians of 3.0, 6.0, and 13.5 months, respectively, after tonsillectomy. The slope of the estimated glomerular filtration rate (eGFR) increased significantly during the 81-month observation period, including the periods before and after tonsillectomy (−2.59 vs 1.05 mL/min/1.73 m2 per year; P < 0.001). The effect on eGFR slope was consistent in 11 patients with reduced GFR (eGFR < 60 mL/min/1.73 m2) at the time of tonsillectomy (−3.07 vs −0.39 mL/min/1.73 m2 per year; P < 0.001). Limitations: Small sample size. Lack of a control (no-tonsillectomy) group due to the difficulty of setting the baseline time point (which corresponded to tonsillectomy in our sample). Potential exclusion of patients with the most severe disease who are likely to receive corticosteroids. Lack of generalizability to patients in other countries. Conclusions: Tonsillectomy monotherapy may prevent kidney function decline in some patients with IgAN with kidney disease that has been progressive despite long-term application of conventional therapies.http://www.sciencedirect.com/science/article/pii/S2590059520301643IgA nephropathytonsillectomyremissionhematuriaproteinuria |
spellingShingle | Hirokazu Marumoto Nobuo Tsuboi Tetsuya Kawamura Takashi Yokoo Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary Kidney Medicine IgA nephropathy tonsillectomy remission hematuria proteinuria |
title | Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary |
title_full | Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary |
title_fullStr | Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary |
title_full_unstemmed | Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary |
title_short | Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary |
title_sort | tonsillectomy monotherapy for iga nephropathy a case seriesplain language summary |
topic | IgA nephropathy tonsillectomy remission hematuria proteinuria |
url | http://www.sciencedirect.com/science/article/pii/S2590059520301643 |
work_keys_str_mv | AT hirokazumarumoto tonsillectomymonotherapyforiganephropathyacaseseriesplainlanguagesummary AT nobuotsuboi tonsillectomymonotherapyforiganephropathyacaseseriesplainlanguagesummary AT tetsuyakawamura tonsillectomymonotherapyforiganephropathyacaseseriesplainlanguagesummary AT takashiyokoo tonsillectomymonotherapyforiganephropathyacaseseriesplainlanguagesummary |